missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CRYM Polyclonal Antibody

Descripción
Peptide sequence: ALTTKLVTFY EDRGITSVVP SHQATVLLFE PSNGTLLAVM DGNVITAKRT Sequence homology: Cow: 79%; Human: 100%.
Crystallins are separated into two classes: taxon-specific and ubiquitous. The former class is also called phylogenetically-restricted crystallins. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. This gene encodes a taxon-specific crystallin protein that binds NADPH and has sequence similarity to bacterial ornithine cyclodeaminases. The encoded protein does not perform a structural role in lens tissue, and instead it binds thyroid hormone for possible regulatory or developmental roles. Multiple alternatively spliced transcript variants have been found for this gene.
Especificaciones
Especificaciones
| Antígeno | CRYM |
| Aplicaciones | Western Blot |
| Clasificación | Polyclonal |
| Concentración | 0.5 mg/mL |
| Conjugado | Unconjugated |
| Formulación | PBS with 2% sucrose and 0.09% sodium azide |
| génica | CRYM |
| N.º de referencia del gen | Q14894 |
| Alias de gen | CDK108; Crym; crystallin mu; crystallin, mu; DFNA40; ketimine reductase mu-crystallin; mu-crystallin homolog; Mu-crystallin-like protein; NADP-regulated thyroid-hormone binding protein; NADP-regulated thyroid-hormone-binding protein; similar to Mu-crystallin homolog (NADP-regulated thyroid-hormone binding protein); THBP; thiomorpholine-carboxylate dehydrogenase |
| Símbolos de los genes | CRYM |
| Mostrar más |
Título del producto
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.
Vous avez repéré une opportunité d'amélioration ?